A Brian Markison

Affiliations

  • Ceo at Lantheus Holdings Inc. (LNTH), 2025-03-07
  • Chief Executive Officer at Rvl Pharmaceuticals Plc (RVLP), 2022-08-09
  • at Organogenesis Holdings Inc. (ORGO), 2018-12-13
  • Director at Immunomedics Inc (IMMU), 2017-11-21
  • Director at Alere Inc. (ALR), 2017-10-03
  • Director at Pharmathene Inc (PIP), 2015-01-06
  • President And Ceo at King Pharmaceuticals Inc (KG), 2011-03-01
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RVLP $1.55 850,000 $1,317,500.00 2,976,020 2022-08-08 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LNTH $81.13 13,290 $1,078,217.70 19,318 2023-03-27 Filing
LNTH $84.84 13,788 $1,169,784.95 32,608 2022-09-08 Filing
LNTH $84.10 23,852 $2,006,043.84 46,396 2022-09-08 Filing
LNTH $83.05 4,172 $346,463.74 70,248 2022-09-08 Filing
LNTH $78.50 1,693 $132,900.50 49,968 2022-09-06 Filing